The OPFR mixture was a combination of tris(1,3-dichloro-2-propyl)phosphate (TDCPP, Sigma Aldrich, St. Louis, MO, CAS#:13674-87-8, 95.6% purity), triphenyl phosphate (TPP, Sigma Aldrich, St. Louis, MO; CAS#:115-86-6, 99% purity), and tricresyl phosphate (TCP, AccuStandard, New Haven, CT, CAS#: 1330-78-5, 99% purity) at 1 mg/kg each. This dose was previously found to be effective in an adult exposure model in mice (Krumm et al 2018 (link)), in our recent maternal exposure study on neonatal and juvenile gene expression (Adams et al 2020 (link)), and in a developmental exposure model in rats focusing on exploratory behavior and locomotion (Baldwin et al 2017 (link); Patisaul et al 2013 (link)). To prepare the OPFR stock, each compound was then dissolved into 1 ml of acetone to create a for a stock solution. 100 μl of stock solution was dissolved into 10ml of sesame oil (Sigma-Aldrich) and allowed to vent for 24–48 h, as previously reported (Krumm et al 2018 (link)).